Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%

CVE-2018-8863— Philips EncoreAnywhere Exposure of Sensitive Information to an Unauthorized Actor

CVSS 5.9 · Medium EPSS 0.13% · P32
Get alerts for future matching vulnerabilitiesLog in to subscribe

I. Basic Information for CVE-2018-8863

Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
Philips EncoreAnywhere Exposure of Sensitive Information to an Unauthorized Actor
Source: NVD (National Vulnerability Database)
Vulnerability Description
The HTTP header in Philips EncoreAnywhere contains data an attacker may be able to use to gain sensitive information.
Source: NVD (National Vulnerability Database)
CVSS Information
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:N/A:N
Source: NVD (National Vulnerability Database)
Vulnerability Type
信息暴露
Source: NVD (National Vulnerability Database)
Vulnerability Title
Philips EncoreAnywhere 信息泄露漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
Philips EncoreAnywhere是荷兰飞利浦(Philips)公司的一款通过 Web 收集和分享患者医嘱依从性数据的完整解决方案。 Philips EncoreAnywhere 2.36.3.3及之前版本存在信息泄露漏洞,该漏洞源于HTTP标头包含攻击者可能能够用来获取敏感信息的数据。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)

Affected Products

VendorProductAffected VersionsCPESubscribe
PhilipsEncoreAnywhere 0 ~ 2.36.3.3 -

II. Public POCs for CVE-2018-8863

#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC

III. Intelligence Information for CVE-2018-8863

登录查看更多情报信息。

IV. Related Vulnerabilities

V. Comments for CVE-2018-8863

No comments yet


Leave a comment